. CT26 tumor growth curves (A) and % of tumor free animals (B) in mice that developed tumor at the vaccination site. CT26 tumor cells were treated with nsPEF (600, 200 ns, 7 kV/cm, 10 Hz) and immediately injected into the flank of syngeneic mice (0.6 × 10 6 cells/mouse). Control groups were vaccinated with PBS. After 7 days, animals were challenged with live cells (0.1 × 10 6 cells/mouse) into the opposite flank. Mean +/− s.e., n = 10, 6 for PBS, and nsPEF groups, respectively. Figure S2 . Full-length immunoblots images for figure 1. For both EL-4 (top panels) and CT26 (bottom panels) membranes were incubated with an anti p-eIF2α, stripped, incubated with an anti-eIF2α to measure the total amount of the protein, and finally incubated with an anti-vinculin antibody. To show specific band sizes in (A) vinculin and marker images were overlaid. Because membranes were not stripped in between eIF2α tot. and vinculin antibody incubations, images show both vinculin (140
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